Plain-English translation of NCT06348459 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a registry study that collects information from patients who have received catheter-based procedures to treat acute pulmonary embolism—a serious condition where blood clots block blood vessels in the lungs. Researchers are documenting how these catheter procedures work, how safe they are, and what outcomes patients experience, using both past medical records and new patient information going forward.
Pulmonary embolism is a life-threatening condition, and while catheter procedures offer a promising treatment option for moderate-to-high-risk cases, doctors need better real-world data about how well these interventions work and what complications may occur. This registry will help improve care for future patients by learning from current and past treatment experiences.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will have your medical information collected as part of the registry—either from your past medical records (if you were treated between 2014 and 2018) or going forward from 2018 onward. The researchers will track information about your catheter procedure, your safety, and your recovery to build a better understanding of how these treatments work. You will not need to do anything special beyond allowing your clinical care information to be recorded and studied.
AI-generated summary from trial data · Sep 24, 2026 · Not medical advice
Spain
Sponsor
Hospital San Carlos, Madrid
Collaborators
Asociación de Cardiología Intervencionista de la Sociedad Española de Cardiología
Enrollment target
~300 participants
Started
September 2018
Primary completion
December 2029
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Pablo Salinas, MD, PhD
Hospital San Carlos, Madrid
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.